fixable viability dye efluor 780 (Thermo Fisher)
99
Structured Review
Thermo Fisher
fixable viability dye efluor 780
Fixable Viability Dye Efluor 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fixable+viability+dye+efluor+780/PBS/bio_rxiv__2025__08__31__672068-227-13-18
Average 99 stars, based on 1 article reviews
Fixable Viability Dye Efluor 780, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fixable+viability+dye+efluor+780/PBS/bio_rxiv__2025__08__31__672068-227-13-18
Average 99 stars, based on 1 article reviews
fixable viability dye efluor 780 - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Recombinase Polymerase Amplification:Article Title: A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune Cells Article Snippet: .. The following antibodies, proteins, and dyes were used: PE- or BV421-conjugated anti-CD33 (clone WM53; BioLegend, San Diego, CA), PE-conjugated anti-mesothelin (clone REA1057; Miltenyi Biotec, Germany), PerCP-conjugated anti-CD19 (clone HIB19; BioLegend), PE- or FitC-conjugated anti-CD3 (clone SK7; BD Biosciences, Franklin Lakes, NJ), BV605-conjugated anti-CD4 (clone RPA-T4; BioLegend), PE-conjugate anti-CD34 to detect RQR8 (clone QBEND/10; Invitrogen, Carlsbad, CA), BV421-conjugated anti-PD-1 (clone EH12.2H7; BioLegend), PE-Cy7-conjugated anti-B2M (clone 2M2, BioLegend) BV650-conjugated anti-CD8 (clone RPA-T8; BioLegend), PE-Cy7-conjugated anti-IL-2 (clone MQ1-17H12; BioLegend), BV421-conjugated anti-IFNγ (clone 4S.B3; BioLegend), APC-conjugated anti-TNFɑ (clone Mab11; BioLegend), BV510-conjugated anti-CD107a (clone H4A3; BD Biosciences), Recombinant:Article Title: A Singular Base Editing Platform for Polyfunctional Multiplex Engineering of Immune Cells Article Snippet: .. The following antibodies, proteins, and dyes were used: PE- or BV421-conjugated anti-CD33 (clone WM53; BioLegend, San Diego, CA), PE-conjugated anti-mesothelin (clone REA1057; Miltenyi Biotec, Germany), PerCP-conjugated anti-CD19 (clone HIB19; BioLegend), PE- or FitC-conjugated anti-CD3 (clone SK7; BD Biosciences, Franklin Lakes, NJ), BV605-conjugated anti-CD4 (clone RPA-T4; BioLegend), PE-conjugate anti-CD34 to detect RQR8 (clone QBEND/10; Invitrogen, Carlsbad, CA), BV421-conjugated anti-PD-1 (clone EH12.2H7; BioLegend), PE-Cy7-conjugated anti-B2M (clone 2M2, BioLegend) BV650-conjugated anti-CD8 (clone RPA-T8; BioLegend), PE-Cy7-conjugated anti-IL-2 (clone MQ1-17H12; BioLegend), BV421-conjugated anti-IFNγ (clone 4S.B3; BioLegend), APC-conjugated anti-TNFɑ (clone Mab11; BioLegend), BV510-conjugated anti-CD107a (clone H4A3; BD Biosciences), other:Article Title: Simulating CD8 T cell exhaustion: A comprehensive approach Article Snippet: Viability was determined using a Staining:Article Title: Simulating CD8 T cell exhaustion: A comprehensive approach Article Snippet: Cells were seeded in a 96 well plate with CM media containing the protein transport inhibitor monensin (BD GolgiStop, 1 in 1000) and CD107a antibody (0.75 μg/mL), with or without OVA (2 μg/mL) for four hours at 37°C in 5% CO 2 . .. Cells were stained with eBioscience Article Title: Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis Article Snippet: .. After extraction from fresh blood, PBMCs (1.5 × 106 cells) were stained with 1 μL/mL of Article Title: Glucose Metabolism Controls Oxidative Burst and Lipid Mediator Production in Neutrophils upon Microbial Challenge Article Snippet: .. In brief, cells were stained with fluorophore-conjugated antibodies ( Table S3 ) and Extraction:Article Title: Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis Article Snippet: .. After extraction from fresh blood, PBMCs (1.5 × 106 cells) were stained with 1 μL/mL of Saline:Article Title: Unknown Immunoregulatory Effects of FcRn Inhibition by Efgartigimod in Myasthenia Gravis Article Snippet: .. After extraction from fresh blood, PBMCs (1.5 × 106 cells) were stained with 1 μL/mL of Selection:Article Title: Purine nucleobases enhance CD8 + T cell effector function Article Snippet: Subsequently, 25 μL of PBS mixed with anti-CD16/32 (Biolegend; dilution 1:200) was added, and the mixture was incubated at room temperature for 10 minutes. .. Then, a 25 μL master mix containing a selection of surface marker antibodies (including anti-CD8.2b, anti-CD3 and others, all from Biolegend at a 1:200 dilution in PBS) along with Marker:Article Title: Purine nucleobases enhance CD8 + T cell effector function Article Snippet: Subsequently, 25 μL of PBS mixed with anti-CD16/32 (Biolegend; dilution 1:200) was added, and the mixture was incubated at room temperature for 10 minutes. .. Then, a 25 μL master mix containing a selection of surface marker antibodies (including anti-CD8.2b, anti-CD3 and others, all from Biolegend at a 1:200 dilution in PBS) along with Incubation:Article Title: Purine nucleobases enhance CD8 + T cell effector function Article Snippet: Subsequently, 25 μL of PBS mixed with anti-CD16/32 (Biolegend; dilution 1:200) was added, and the mixture was incubated at room temperature for 10 minutes. .. Then, a 25 μL master mix containing a selection of surface marker antibodies (including anti-CD8.2b, anti-CD3 and others, all from Biolegend at a 1:200 dilution in PBS) along with |